mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.001 |
mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
0.14 |
0.002 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.002 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.002 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.003 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.004 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.005 |